Nanexa AB (publ) NANEXA

Updated: 9 Aug 2026

NASDAQ | Biotech | Pharmaceutical development and drug delivery

No signal published yet

We already track Nanexa and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow Nanexa free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NASDAQ
Type
Biotech
Sector
Pharmaceutical development and drug delivery
We're already tracking Nanexa AB (publ) — here are the latest events we've registered

Recent News

  • In April 2026, Nanexa announced that all warrants issued in spring 2025 had been exercised, generating approximately SEK 55.7 million before transaction costs. Additionally, the board resolved to set off the company's entire outstanding loan of SEK 20 million through a set-off share issue. Nanexa also published its Q1 2026 interim report in April 2026.

What Firelda Watch includes for Nanexa AB (publ)

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Nanexa AB (publ) will be delivered in the same format.

Want to follow Nanexa AB (publ)? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow Nanexa free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Nanexa AB (publ) NANEXA
Nanexa — follow and we'll monitor it
Follow Nanexa free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.